1. Sullivan L. Defining “quality that matters” in clinical trial study startup activities. Monitor. 2011;25:22–26.
2. Li G, Harper B, Sirabella L. Activating investigative sites in a staggered process: challenges and solutions. In: Parexel Biopharmaceutical R&D Statistical Sourcebook 2011/2012. Waltham, MA; PAREXEL International Corp; 2011:175–177.
3. Manak D, Chung J, Reuter S. Study startup 2.0: reinventing how clinical trials begin. Monitor. 2011;25:33–38.
4. Panzitta D. Avoiding the 5 common mistakes at study startup. Available at: http://www.appliedclinicaltrialsonline.com. Accessed July 27, 2010.
5. Korieth K. Budding relationships. In: European Pharmaceutical Contractor. London, UK; Samedan Ltd Publishers; 2011:10–14.